XML 32 R14.htm IDEA: XBRL DOCUMENT v3.24.1
Note 5 - Income Tax Provision
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

Note 5.

Income Tax Provision

 

USAC files federal income tax returns based on the type of return. USAC files a consolidated corporate federal income tax return with USAMC and USAIC. USASLC, and USALSC-MT file a consolidated life insurance federal income tax return. Certain items included in income reported for financial statement purposes are not included in taxable income for the current period, resulting in deferred income taxes.

 

A reconciliation of federal income tax expense computed by applying the federal income tax rate of 21% to income before federal income tax expense for the years ended December 31, 2023 and 2022, respectively, is summarized as follows:

 

  

2023

  

2022

 

Income (loss) before total federal income tax

  625,729   (3,305,485)

Tax rate

  21%  21%

Expected income tax expense (benefit)

  131,403   (694,152)

Effect of tax-exempt income

  (28,448)  (19,204)

Other

  6,908   - 

State income tax, net

  25,749   66,793 

Return-to-Provision adjustments

  (89,557)  (25,529)

Prior period adjustments

  2,741   13,334 

Change in valuation allowance

  (901,143)  509,758 

Total

  (852,347)  (149,000)

 

For the year ended December 31, 2023, the Company recognized total tax benefit of $(852,347). This benefit is comprised of current tax expense of $0 and a deferred tax benefit of $(852,347). For the year ended December 31, 2022, the Company recognized a total tax benefit of $(149,000). 

 

Deferred taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amount used for income tax purposes. Significant components of the Company's deferred tax liabilities and assets as of December 31, 2023 and 2022 are summarized as follows:

 

  12/31/2023  12/31/2022 

Deferred Tax Assets

        

Net operating and capital loss carryforwards

  2,055,140   2,364,039 

Unamortized start-up costs

  84,402   105,502 

Policyowner benefit reserves

  2,353,584   2,752,406 

Unrealized Losses

  887,427   1,367,975 

Tax DAC

  903,654   824,896 

Deferred tax asset valuation allowance

  (341,684)  (1,834,167)
   5,942,523   5,580,651 

Deferred Tax Liabilities

        

GAAP DAC

  993,388   1,177,664 

Fixed assets

  89,760   29,945 

8 Year Spread

  77,810   116,715 

Value of business acquired

  509,454   528,862 

Other GAAP to Tax Differences

  383,203   432,943 

Unrealized gains

  -   - 
   2,053,616   2,286,129 
         

Net Deferred Tax

  3,888,907   3,294,522 

 

The Company has federal net operating loss ("NOL") and capital loss carryforwards of $7,425,956 and $9,630,952 as of December 31, 2023 and 2022, respectively. The federal NOLs generated in the years ended December 31, 2009 through 2017 will begin to expire in 2027 for federal income tax purposes. NOLs originating before January 1, 2018 are eligible to offset taxable income, if not otherwise limited under Internal Revenue Code ("IRC") section 382 limitations. NOLs generated after December 31, 2017, have an indefinite carryforward period and are subject to 80% deduction limitations based upon pre-NOL taxable income.

 

At December 31, 2023 the Company changed its tax reserve discounting methodology relating to the cash surrender value of life insurance policies. As a result of this change in method, the Company recognized an additional deferred tax benefit.